Entry to 4,5-fused coumarin frameworks via radical-promoted alkylative intramolecular C5-annulation
Organic & Biomolecular Chemistry · 2024 · 22 (31) · 6385-6392
DOI: 10.1039/d4ob00942h ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic & Biomolecular Chemistry, 2024. Verfasst von Chada Raji Reddy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad - 500007, India. rajireddy@iict.res.in. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
A silver-catalyzed oxidative protocol for the synthesis of previously unfamiliar 4,5-fused coumarins is disclosed.
Autor:innen und Institutionen
- Department of Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad - 500007, India. rajireddy@iict.res.in.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201 002, India.
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Raji Reddy, C., Edhara, V., Kumari, A., Patil, A. D., & Thandavamurthy, K. (2024). Entry to 4,5-fused coumarin frameworks via radical-promoted alkylative intramolecular C5-annulation. Organic & Biomolecular Chemistry, 22(31), 6385-6392. https://doi.org/10.1039/d4ob00942h
Vancouver
Raji Reddy C, Edhara V, Kumari A, Patil AD, Thandavamurthy K. Entry to 4,5-fused coumarin frameworks via radical-promoted alkylative intramolecular C5-annulation. Organic & Biomolecular Chemistry. 2024;22(31):6385-6392. doi:10.1039/d4ob00942h
BibTeX
@article{RajiReddy2024,
author = {Raji Reddy, Chada and Edhara, Venkatareddy and Kumari, Ankita and Patil, Amol D and Thandavamurthy, Karthikeyan},
title = {Entry to 4,5-fused coumarin frameworks via radical-promoted alkylative intramolecular C5-annulation},
journal = {Organic & Biomolecular Chemistry},
year = {2024},
volume = {22},
number = {31},
pages = {6385--6392},
doi = {10.1039/d4ob00942h}
}
EUVIMED